Sicktitties.org
\
THE PROBLEM
Millions of women navigate a healthcare system that frequently misunderstands and misdiagnoses complex breast implant-related illnesses, creating a critical gap in research, care, and economic burden.
The Crisis in Numbers
10M+
Women Worldwide
Currently living with breast implants.
1 in 3
Report BII Symptoms
Consistent with Breast Implant Illness.
84%
Misdiagnosed
For 5-25+ years, often labeled anxious or somatic.
0
Peer-Reviewed Studies
Analyzing long-term systemic implant impact.
The Triad: How Breast Implants, BII, and Cancer Intersect
Breast Cancer → Implants
Approx. 2 million breast cancer survivors are implant patients, often receiving them after immune-compromising treatments.
Implants → Cancer Risk
Higher rates of delayed cancer detection due to imaging obstruction, capsular contracture, and symptoms masking recurrence.
Implants → Lymphoma
Over 1,300 confirmed cases of BIA-ALCL globally, linked specifically to breast implants.

The Hidden Stat Nobody Is Tracking
Breast cancer survivors are the largest high-risk group for BII and BIA-ALCL, yet they receive implants post-chemo, radiation, and hormonal suppression, increasing systemic vulnerability.
The Economic Failure
$28K+
Explant + Recovery
Average cost, almost never covered by insurance.
$1M+
Lifetime Burden
For misdiagnosed BII and cancer-adjacent illness.
$4.2B
Wasted Medical Spending
From misdiagnosis, imaging, and unnecessary treatments.
The Momentum and Opportunity
Momentum is Building
  • 1 Million Women in the SickTitties.org awareness & survivor community.
  • UN-recognized mission for the first AI-driven, peer-reviewed clinical trial for the Triad of Women’s Health.
NobleCareAI.org: The Opportunity
The first platform to track BII, BIA-ALCL, and Breast Cancer as one interconnected disease environment. An AI-powered engine delivering diagnosis, data, financing, and survivorship – built for millions of women who have been invisible in the data, until now.
OUR STORY
How NobleCare™ Began
Born from personal battles and systemic failure, two women—Kristin Nobles and Dr. Tawana Angela Davis—ignited a revolution in women's health. They built the world's first AI-powered clinical research and diagnostic engine for breast implant-related illness, autoimmune disease, and emerging implant-associated cancers.
The Catalyst: Systemic Failure
Breast Implant Illness affects over 20 million women worldwide, leading to chronic misdiagnosis, severe health decline, and life-threatening cancers. This widespread suffering, ignored by traditional healthcare, became the urgent call to action for our founders.
A New Foundation for Health
Kristin and Dr. Tawana formed a groundbreaking infrastructure, uniting survivor truth, academic rigor, AI innovation, and community healing. Their vision: to create a system that could finally diagnose, protect, and support millions.
Assembling a Super-Group
They then built an unparalleled team of experts, including Christine Torres, Dr. Theresa Ashby, Dan Witzling, Dirk Armbrust, Dublin Wahlberg, and Chandra Challagonda. This collective brings legal insight, AI strategy, storytelling power, and enterprise governance, committed to reforming women's healthcare from the ground up.
What we are designing is not merely a product; it’s a powerful new infrastructure capable of achieving what institutions would not—a future where millions of women are diagnosed, protected, and supported.
WHO WE ARE
We're the first patient-led, AI-powered research group focused on the triad of breast health — Breast Implant Illness (BII), BIA-ALCL, and breast cancer — turning lived experience into science, and science into action.
We're a 501(c)(3) research organization born out of thousands of days in hospitals, misdiagnoses, second opinions, and "it's all in your head." Spoiler: it wasn't.
Noble Care AI Research Group exists to:
Study the real impact of breast implants and related conditions
Build the first AI-driven, peer-reviewed clinical trial platform for the breast health triad
Protect and empower patients with data, not gaslighting
We sit at the intersection of:
Patients & Survivors
the ones who've lived this
Clinicians & Researchers
the ones ready to do the work
Technologists
the ones building the AI engine
Donors, Sponsors & Impact Investors
the ones who understand that health equity is the smartest investment on the planet
And yes, we are proudly connected to SickTitties.org – the media and movement arm that keeps things honest, human, and impossible to ignore.
OUR SOLUTION
A Patient-Led Clinical Trial Model
Traditional research often treats patients like data points. We treat them like co-authors.
The AI-Powered Research Platform
We're building an engine that allows patients to opt in and share:
Medical records & imaging
Pathology & lab results
Genetics and biometrics (for those who choose)
Lived experience, symptoms, and outcomes
Our AI tools help researchers:
Spot patterns and correlations faster
Compare outcomes across procedures, implants, treatments, and timelines
Ask new questions
that were invisible in siloed data
We work with open, ethical technology partners and keep patient consent, privacy, and control at the center of everything.
MEET THE FOUNDERS
SickTitties.org™ & NobleCare.ai™ Leadership
Our leadership team combines decades of expertise in healthcare, media, technology, and finance. Each founder brings professional excellence and personal purpose to redefine women's health through innovation, transparency, and care.
Kristin Nobles
CEO & Founder
A Silicon Valley founder with 25+ years in finance, tech, and media, Kristin turned her health battle into a global movement. She leads NobleCare.ai™, an AI healthcare app, and spearheads ethical, open-source infrastructure. Her vision transforms advocacy into media and research, funding women’s health.
Reverend Doctor Tawana Angela Davis
President & Co-Founder
Minister, scholar, and human-rights advocate, Dr. Davis bridges compassion with innovation. A breast cancer thriver who also faced BII, she brings vital personal insight and operational leadership. She ensures empathy and equity are central, shaping our unified, community-driven care ecosystem.
Christine Torres
Chief Strategy Advisor & Co-Founder
An award-winning producer, former prosecutor, and media strategist, Christine brings truth and accountability. Her background from Law & Order to global impact campaigns ensures our narratives are accurate, ethical, and rooted in lived experience, driving advocacy into global awareness.
Dirk Armbrust
Chief Financial Officer
Co-Founder of B Noble Impact Accelerator, Dirk has been integral to our mission from the start. An experienced M&A advisor, he ensures every dollar translates into measurable impact. His expertise helps transform our bold vision into a viable, scalable, and self-sustaining enterprise.
Dublin Wahlberg
Chief Operating Officer
Writer, actor, producer, and angel investor, Dublin drives impact through storytelling and advocacy. As an advisor and executive producer, he curates events and campaigns, amplifying awareness for women’s health. His artistic insight and business discipline embody our commitment to real-world change.
Chandra Challagonda
Chief Technology Officer
Recognized as a top AI and data infrastructure mind, Chandra leads the design and deployment of our core technology. His leadership, experience, and access to FIWARE.org position NobleCare.ai™ as a tech innovator, advancing women’s health and global technology standards.
United by purpose and powered by technology, our team is rewriting the story of women’s health—one breakthrough at a time.
THE ADVISORY BOARD
Our esteemed Advisory Board comprises leaders from diverse fields, bringing a wealth of experience to guide our strategic direction and ensure our mission's success.
Dan Witzling
Strategic Advisor, Capital Systems & Health Impact
A seasoned public health and nonprofit executive, Dan brings extensive experience in enterprise strategy, fintech innovation, and digital health. His background includes leadership roles at Bioscience Los Angeles County Inc. and the American Cancer Society. Dan advises on critical areas such as capital systems, payer-model innovation, and health infrastructure partnerships, ensuring our financial and operational strategies align with maximum impact.
Dr. Theresa Ashby
Governance, Scale & Organizational Architecture Advisor
Dr. Ashby is a global consultant and expert in governance and organizational architecture, with a focus on scaling mission-driven companies. She provides invaluable guidance on operational infrastructure, compliance, and board development, helping us build a robust and ethical framework for enterprise-level expansion. Her expertise is crucial in navigating growth while maintaining our core social impact mission.
Each member is deeply committed to revolutionizing women's breast health through ethical innovation and strategic leadership.
Get In Touch
We're eager to connect with patients, researchers, technologists, and partners who share our vision for a healthier future in women's breast health.
General Inquiries
For questions about NobleCare AI Research Group, supporting our research or general information:
Partnerships & Support
Interested in collaborating on events fundraisers or media inquiries?
Follow us on social media for updates and community engagement.